Published Studies Related to Lithium Citrate
Well-designed clinical trials related to Lithium Citrate
Lithium lacks effect on survival in amyotrophic lateral sclerosis: a phase IIb
randomised sequential trial. [2012]
Efficacy and safety of lithium carbonate treatment of chronic spinal cord injuries: a double-blind, randomized, placebo-controlled clinical trial. [2011.11.22]
Continuation of quetiapine versus switching to placebo or lithium for maintenance treatment of bipolar I disorder (trial 144: a randomized controlled study). [2011.11]
Treatment of suicide attempters with bipolar disorder: a randomized clinical trial comparing lithium and valproate in the prevention of suicidal behavior. [2011.10]
Dosing strategies for lithium monotherapy in children and adolescents with bipolar I disorder. [2011.06]
Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial. [2011.05]
Six-year clinical performance of lithium disilicate fixed partial dentures. [2011.05]
Comparative reliability analyses of zirconium oxide and lithium disilicate restorations in vitro and in vivo. [2011.04]
Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study. [2011.03]
Paliperidone extended-release as adjunctive therapy to lithium or valproate in the treatment of acute mania: a randomized, placebo-controlled study. [2011.03]
Double-blind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania. [2011.03]
Long-term outcome of bipolar depressed patients receiving lamotrigine as add-on to lithium with the possibility of the addition of paroxetine in nonresponders: a randomized, placebo-controlled trial with a novel design. [2011.02]
Lithium carbonate pre-treatment in 131-I therapy of hyperthyroidism. [2011]
Estimation of resource utilisation difference between lithium and valproate treatment groups from the VALID study. [2011]
Treatment of suicide attempters with bipolar disorder: a randomized clinical
trial comparing lithium and valproate in the prevention of suicidal behavior. [2011]
Differential pattern of response in mood symptoms and suicide risk measures in
severely ill depressed patients assigned to citalopram with placebo or citalopram
combined with lithium: role of lithium levels. [2011]
Comparison of paroxetine and amitriptyline as adjunct to lithium maintenance therapy in bipolar depression: a reanalysis of a randomized, double-blind study. [2010.11]
A double-blind, placebo-controlled study with quetiapine as adjunct therapy with lithium or divalproex in bipolar I patients with coexisting alcohol dependence. [2010.10]
Efficacy and safety of two treatment algorithms in bipolar depression consisting of a combination of lithium, lamotrigine or placebo and paroxetine. [2010.09]
Lithium carbonate in amyotrophic lateral sclerosis: lack of efficacy in a dose-finding trial. [2010.08.17]
Tensile bond strength of a lithium-disilicate pressed glass ceramic to dentin of different surface treatments. [2010.08.07]
Lamotrigine versus lithium as maintenance treatment in bipolar I disorder: an open, randomized effectiveness study mimicking clinical practice. The 6th trial of the Danish University Antidepressant Group (DUAG-6). [2010.08]
Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study. [2010.07]
Lithium-induced gray matter volume increase as a neural correlate of treatment response in bipolar disorder: a longitudinal brain imaging study. [2010.07]
Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial. [2010.05]
Olanzapine vs. lithium in management of acute mania. [2010.05]
Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12-week trial. [2010.03]
A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I). [2010.02]
Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. [2010.01.30]
Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. [2010.01.30]
Lithium's emerging role in the treatment of refractory major depressive episodes: augmentation of antidepressants. [2010]
A double-blind, placebo-controlled study with quetiapine as adjunct therapy with
lithium or divalproex in bipolar I patients with coexisting alcohol dependence. [2010]
Safety and efficacy of lithium in combination with riluzole for treatment of
amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled
trial. [2010]
Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar
II disorder: a randomized, double-blind, placebo-substitution study. [2010]
Effect of Early Intervention with Omega-3 on Insulin Resistance in Patients
Initiated on Olanzapine with either Sodium Valproate or Lithium: A randomized,
Double-blind, Placebo-Controlled Trial. [2010]
Olanzapine vs. lithium in management of acute mania. [2010]
Lithium treatment -- moderate dose use study (LiTMUS) for bipolar disorder: rationale and design. [2009.12]
Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study. [2009.06]
Comparison between lithium dilution and pulse contour analysis techniques for cardiac output measurement in isoflurane anaesthetized ponies: influence of different inotropic drugs. [2009.05]
Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in combination with lithium or divalproex (trial 127). [2009.04]
Increase of BDNF serum concentration in lithium treated patients with early Alzheimer's disease. [2009.03]
Bipolar I and II disorder residual symptoms: Oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial. [2009.02.01]
Randomized double-blind placebo-controlled trial of lithium in youths with severe mood dysregulation. [2009.02]
Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial. [2009.02]
Comparison of carbamazepine and lithium in treatment of bipolar disorder: a systematic review of randomized controlled trials. [2009.01]
Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial. [2009.01]
A 6-month, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and Co-occurring substance abuse or dependence. [2009.01]
Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study. [2009.01]
[Open randomized comparative twelve-week study of lithium and valproate in manic episode] [2009]
Cost-effectiveness of quetiapine with lithium or divalproex for maintenance treatment of bipolar I disorder. [2009]
Increase of BDNF serum concentration in lithium treated patients with early Alzheimer's disease. [2009]
A single blind comparison of lithium and lamotrigine for the treatment of bipolar II depression. [2008.12]
Verapamil augmentation of lithium treatment improves outcome in mania unresponsive to lithium alone: preliminary findings and a discussion of therapeutic mechanisms. [2008.12]
Adjunctive lithium treatment in the prevention of suicidal behaviour in depressive disorders: a randomised, placebo-controlled, 1-year trial. [2008.12]
Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/lithium monotherapy: a placebo-controlled study. [2008.10]
A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode. [2008.09]
Lithium-induced nephrogenic diabetes insipidus: renal effects of amiloride. [2008.09]
The Collaborative Lithium Trials (CoLT): specific aims, methods, and implementation. [2008.08.12]
A double-blind, randomized, placebo-controlled 4-week study on the efficacy and safety of the purinergic agents allopurinol and dipyridamole adjunctive to lithium in acute bipolar mania. [2008.08]
A Double-Blind, Randomized, Placebo-Controlled 4-Week Study on the Efficacy and Safety of the Purinergic Agents Allopurinol and Dipyridamole Adjunctive to Lithium in Acute Bipolar Mania. [2008.07.29]
Lithium-induced Nephrogenic Diabetes Insipidus: Renal Effects of Amiloride. [2008.07.02]
A double-blind, randomized, placebo-controlled prophylaxis trial of oxcarbazepine as adjunctive treatment to lithium in the long-term treatment of bipolar I and II disorder. [2008.06]
Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: A randomized, parallel group, open-label trial. [2008.05.15]
Serotonin transporter gene and response to lithium augmentation in depression. [2008.04]
Comparison of Short-Term Venlafaxine Versus Lithium Monotherapy for Bipolar II Major Depressive Episode: A Randomized Open-Label Study. [2008.04]
Olanzapine or lamotrigine addition to lithium in remitted bipolar disorder patients with anxiety disorder comorbidity: a randomized, single-blind, pilot study. [2008.04]
What is the optimal serum lithium level in the long-term treatment of bipolar disorder--a review? [2008.03]
Response and remission rates in Chinese patients with bipolar mania treated for 4 weeks with either quetiapine or lithium: a randomized and double-blind study. [2008.01]
Olanzapine versus lithium in the acute treatment of bipolar mania: A double-blind, randomized, controlled trial. [2008.01]
FDG-PET study in pathological gamblers. 1. Lithium increases orbitofrontal, dorsolateral and cingulate metabolism. [2008]
Initial symptoms of manic relapse in manic or mixed-manic bipolar disorder: post hoc analysis of patients treated with olanzapine or lithium. [2007.10]
Lithium augmentation compared with phenelzine in treatment-resistant depression in the elderly: an open, randomized, controlled trial. [2007.08]
A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania. [2007.07]
Lithium versus lamotrigine augmentation in treatment resistant unipolar depression: a randomized, open-label study. [2007.05]
Are serum lithium levels related to the polarity of recurrence in bipolar disorders? Evidence from a multicenter trial. [2007.05]
Valproate or olanzapine add-on to lithium: an 8-week, randomized, open-label study in Italian patients with a manic relapse. [2007.04]
Quetiapine augmentation of treatment-resistant depression: a comparison with lithium. [2007.02]
Serum lithium concentration can be used to assess dietary compliance in adults. [2004.11]
Oral choline decreases brain purine levels in lithium-treated subjects with rapid-cycling bipolar disorder: a double-blind trial using proton and lithium magnetic resonance spectroscopy. [2003.08]
Endocrine effects of lithium carbonate in healthy premenopausal women: relationship with body weight regulation. [2000.01]
Acute mania: haloperidol dose and augmentation with lithium or lorazepam. [1999.12]
Treatment of manic episodes: zuclopenthixol and clonazepam versus lithium and clonazepam. [1996.02]
Effect of sodium polystyrene sulfonate on lithium bioavailability. [1992.11]
Lithium absorption prevented by sodium polystyrene sulfonate in volunteers. [1992.11]
Bioavailability of lithium from lithium citrate syrup versus conventional lithium carbonate tablets. [1992.10]
Two regimens of lithium prophylaxis and renal function. [1989.12]
Sodium, lithium-countertransport and blood pressure control by nutritional intervention in 'mild' hypertension. [1988.04]
Well-designed clinical trials possibly related to Lithium Citrate
Topiramate as an adjuvant treatment for obsessive compulsive symptoms in patients
with bipolar disorder: a randomized double blind placebo controlled clinical
trial. [2014]
Comparative efficacy and acceptability of drug treatments for bipolar depression:
a multiple-treatments meta-analysis. [2014]
Allopurinol for mania: a randomized trial of allopurinol versus placebo as add-on
treatment to mood stabilizers and/or antipsychotic agents in manic patients with
bipolar disorder. [2014]
Valproic acid, valproate and divalproex in the maintenance treatment of bipolar
disorder. [2013]
Characterizing relapse prevention in bipolar disorder with adjunctive
ziprasidone: clinical and methodological implications. [2013]
The paroxetine 352 bipolar trial: A study in medical ghostwriting. [2012]
Quetiapine: a pharmacoeconomic review of its use in bipolar disorder. [2012]
Treatment of mixed bipolar states. [2012]
Asenapine as adjunctive treatment for acute mania associated with bipolar
disorder: results of a 12-week core study and 40-week extension. [2012]
Polarity index of pharmacological agents used for maintenance treatment of
bipolar disorder. [2012]
Modeling drop-outs in amyotrophic lateral sclerosis. [2012]
Ziprasidone with adjunctive mood stabilizer in the maintenance treatment of
bipolar I disorder: long-term changes in weight and metabolic profiles. [2012]
Efficacy and safety of adjunctive oral ziprasidone for acute treatment of depression in patients with bipolar I disorder: a randomized, double-blind, placebo-controlled trial. [2011.10]
Comorbid anxiety disorders and baseline medication regimens predict clinical outcomes in individuals with co-occurring bipolar disorder and alcohol dependence: Results of a randomized controlled trial. [2011.08.15]
|